1. Introduction {#sec0005}
===============

Feline coronaviruses (FCoVs) are enveloped, positive-sense, single-stranded RNA viruses classified as "subgroup 1a" in the family *Coronaviridae* within the order *Nidovirales* ([@bib0200]). FCoVs consist of two biotypes designated as feline enteric coronavirus (FECV) and feline infectious peritonitis virus (FIPV), which are both divided into two serotypes, I and II. Serotype I is of feline origin and difficult to grow in cell culture. Serotype II appears to have arisen from the recombination of FCoV serotype I with canine coronavirus and grows rapidly in cell culture causing a lytic cytopathic effect ([@bib0020]; [@bib0075], [@bib0125]). It is thought that the FIPV biotype may arise from FECVs in individual cats by internal mutation, often in immune suppressed cats ([@bib0135], [@bib0195]). An alternative hypothesis is that FECVs and FIPVs form distinct viral populations with infection by FIPV causing FIP ([@bib0025]).

FCoVs are transmitted by the fecal--oral route and the virus can persist on fomites for 3--7 weeks where they pose a risk of transmission ([@bib0075], [@bib0125], [@bib0100]). FCoVs primarily infect enterocytes and spread from the intestine by monocyte-associated viremia ([@bib0070], [@bib0095]). They have also been shown to replicate in monocytes/macrophages of healthy cats ([@bib0030], [@bib0050]). Vertical transmission has not been demonstrated ([@bib0055]). Persistently infected, asymptomatic carriers spread FCoV since most of these cats shed the virus for a period of months or years, either continuously or transiently ([@bib0055], [@bib0035], [@bib0050], [@bib0100], [@bib0150]).

The symptoms of FCoV infection are highly variable. Most FCoV-infected cats look healthy with the exception of a mild enteritis ([@bib0125]). Up to 12% of FCoV infected cats develop feline infectious peritonitis (FIP), which is a fatal form of the infection ([@bib0005]). Development of FIP is strongly associated with stress, immunity, multicat households and mainly occurs in young cats between 3 and 16 months of age ([@bib0035], [@bib0075], [@bib0015], [@bib0005], [@bib0210]). Clinically, two forms of FIP are well documented: a 'wet' or effusive form (polyserositis and vasculitis) and a 'dry' or non-effusive form (pyogranulomatous lesions in organs) ([@bib0095]). Ascites is the most prominent manifestation of 'wet form' FIP while lethargy, anorexia, weight loss and fever refractory to antibiotics are common and non-specific signs of FIP ([@bib0095], [@bib0005]).

Diagnosis of FIP is complicated and the cat\'s clinical history together with results from several analyses including serology, PCR and postmortem analyses are often required before a definite diagnosis can be reached ([@bib0165], [@bib0080], [@bib0010], [@bib0005], [@bib0145], [@bib0160], [@bib0185]). Hematological and biochemical changes in FIP cases are not very specific, but ascites, increase in serum protein level, increase in bilirubin, decrease in hematocrit and decrease in A:G ratio are prominent ([@bib0005]). Serological tests may fail to detect recent infections and cross-reactions occur between FIPV and low pathogenic FECV strains ([@bib0075], [@bib0160]). Molecular detection systems like standard and real time reverse transcription polymerase chain reaction (PCR) have certain advantages as they are rapid and sensitive, particularly when using abdominal or pleural fluidor tissue biopsy or aspirates ([@bib0125], [@bib0160]). A recent PCR test that is commercially available (FIP Virus RealPCR™ Test, IDEXX) allows differentiating FIPV and low pathogenic FECV biotypes, and according to the manufacturers, the test was 99.4% accurate in samples from 88% infected cats with a positive PCR result. PCR results should be evaluated together with clinical findings and postmortem samples should be analyzed by molecular methods ([@bib0170], [@bib0080], [@bib0145], [@bib0005], [@bib0125], [@bib0160]).

Worldwide the prevalence of FCoV infections may be up to 90% in multi-cat environments and 10--60% in household cats ([@bib0085], [@bib0120], [@bib0015], [@bib0005], [@bib0155], [@bib0180]). Detection of FCoV antibodies in the early stage of infection can be useful to minimize the spread of FCoVs in a breeding cattery, multi-cat household and FCoV-free household ([@bib0035], [@bib0050], [@bib0045]). Therefore, it is important to monitor cats living in multi-cat environments in order to reduce and control FCoV infection.

The aim of this study was to investigate FCoV seroprevalence and its relationship with the animal\'s signalment, habitat, hematological and biochemical parameters and symptoms in cats from Istanbul.

2. Materials and methods {#sec0010}
========================

2.1. Study population and sampling {#sec0015}
----------------------------------

During 5 years, from January 2009 to April 2014, a total of 169 cats with symptoms compatible with feline viral infections were included in the study population. They included individuals with fever, depression, dullness and/or weight loss. They were examined by two different veterinarians working at a private Veterinary Clinic in Istanbul. The animals' gender, breed, age and hábitat whether household, shelter or street (stray cats) was recorded. Other data from household cats included if they were adopted or home raised from birth, they cohabitated with other cats and had outdoor access.

Cats were clinically examined to detect fever, skin lesions, behavioral changes (insidious onset, depression) and symptoms related to organ systems were recorded; specifically, cardiorespiratory (dyspnea, abnormal heart and lung sounds), gastrointestinal (anorexia, weight loss, stomatitis, enteritis, abdominal distension, vomication, ascites), urinary, circulatory (lymphoadenopathy, anemia, icterus), ocular lesions (keratic precipitates, uveitis, hyphema, iridocyclitis, chorioretinitis) and central nervous system (epileptic seizures, ataxia) symptoms.

Blood samples were taken from the cephalic vein by the veterinarians examining the cats for hematological and biochemical analyses and to detect antibodies against FCoV and feline immunodeficiency virus (FIV) together with feline leukemia virus (FeLV) antigen as described below. All analysis except FCoV IFAT antibodies were carried out at the veterinary clinic within an hour of taking the blood sample. IFAT tests and protein electrophoresis were carried out at an external private veterinary laboratory.

Disease progression of the study cats was evaluated during repeat visits to the clinic and mortality was considered to be associated to the current infection when the cat did not respond to standard treatments which included fluid and antibiotic therapy.

2.2. Analysis of serum samples for antibodies to FCoV and FIV and for FeLV antigen {#sec0020}
----------------------------------------------------------------------------------

All serum samples (*n*  = 169) were analyzed by rapid tests for the presence of antibodies to FCoV (Bionote, Anigen, FCoV) and FIV (Bionote, Anigen FIV Ab), and FeLV antigen (Bionote, FeLV Ag) following kits' instructions. According to the manufacturers, the sensitivity (Se) and specificity (Sp) of the FCoV test compared to the reference immunofluorescence antibody test (IFA) were 96.0% and 97.9%, respectively, Se and SP of the FeLV test versus virus isolation were 94.7% and 99.7%, respectively, and that of the FIV tests versus Western Blot were 96.8% and 99.6%, respectively. Sera found to be positive for antibodies to FCoV by the rapid test were analyzed by IFA in an external private laboratory to confirm the result. Serum giving fluorescence at a dilution above 1:20 was considered positive for antibodies against this virus.

2.3. Hematological and biochemical analyses {#sec0025}
-------------------------------------------

All blood samples were analyzed for a complete blood hemogram--histogram (18 parameters) using a Veterinary Specific Mindray blood analyzing kit and the Hemogram Instrument (Mindray). Samples were also analyzed for comprehensive blood biochemistry (14 parameters); 60 samples were analyzed using the Vet-Scan (Abaxis) kit and the remaining samples were analyzed using Reflotron (Roche) kit. Serum protein electrophoresis was performed for serum samples positive for antibodies to FCoV. Ascitic fluid from 14 cats was analyzed for albumin/globulin (A:G) ratio. Hematological and biochemical tests included total white blood cell count (WBC), lymphocyte and red blood cell counts, hematocrit, hemoglobin, total protein, albumin (alb.), globulin (glob.), alkaline phosphatase (ALP), alanine transaminase (ALT), amylase, total bilirubin, blood urea nitrogen (BUN), creatinine, glucose, calcium, phosphorus, sodium and potassium.

2.4. Statistical analyses {#sec0030}
-------------------------

Data were analyzed using R (<http://cran.r-project.org/>) software. Approximately unbiased estimates of prevalence were calculated assuming known values of test Se and Sp using the Rogan--Gladen statistic ([@bib0060]). Yates-corrected chi squared test, or when appropriate Fisher\'s exact test ([@bib0105]), was used to compare the proportion of FCoV seropositive cats according to cat demographic and habitat explanatory variables and the proportion of signs in FCoV seropositive and seronegative cats. Biochemical and hematological results were categorized as being within (normal), above (high) or below (low) reference values ([@bib0205]).

The independent relationship between FCoV serological status, and a cat\'s demographic, habitat and FIV serological status was further investigated using logistic regression analysis ([@bib0110]). FCoV was the binary outcome variable (seropositive or seronegative). The explanatory variables included those associated at *p*  \< 0.05 with FCoV serological status in the univariable analysis; they were FIV serological status, age, examination year and the variable reflecting living place, outdoor access and contact with other cats ([Table 1a](#tbl0005){ref-type="table"}, [Table 1b](#tbl0010){ref-type="table"} ). All variables were included in the model as categorical variables as shown in [Table 1a](#tbl0005){ref-type="table"}, [Table 1b](#tbl0010){ref-type="table"}, except age, which included seven levels after combining data from 4 to 15 year old cats into a single level. Model parameters were estimated using the maximum likelihood estimation method and significance was taken for alpha less than 5% for a double sided test.Table 1aPercentage of FCoV seropositive cats according to examination year, gender, breed, and age.VariablesLevel*N*No. seropositive% seropositive95% CI*p* valueLowerUpperStudy year200913931656\<0.00012010201525644201119171102420123524311647201352363118432014305837097  GenderFemale70424029510.6499Male9964352645  BreedCross breed142883830460.8062Pure breed2718331651  Age (years)0.1--0.42520204360.20310.6--0.81383812651382242265822412503070324125030704--51613190386--914102955210--15159401565Table 1bPercentage of FCoV seropositive cats according to origin, habitat and FIV status.VariablesLevel*N*No. seropositive% seropositive95% CI*p* valueLowerUpperHomeHousehold122734031490.2835Street4733301743  OriginHome raised5023544068\<0.0001Pet shop166633986Shelter adopted30100100100Street adopted10077261834  Outdoor accessNo75532919400.0805Yes9453443454  Cohabitating with other catsNo3712142250.0014Yes13294443552  Home; outdoor access; cohabitating with other catsStreet, yes; yes47333017430.0002House; no; no373214225House; no; yes3721432759House; yes; yes4720574372

3. Results {#sec0035}
==========

3.1. Estimated FCoV and FIV seroprevalence and FeLV prevalence {#sec0040}
--------------------------------------------------------------

Antibodies to FCoV and FIV were detected in 63/169 and 19/169 cats. Two out of 169 cats were positive for FeLV antigen. The estimated FCoV and FIV seroprevalence and FeLV prevalence (95% CI) adjusted for tests Se and Sp, were 37% (30--45%), 11% (6--16%) and 1% (0--3%), respectively. All cats testing FCoV antibody positive to the rapid test were also IFAT antibody positive.

3.2. Relationship between FCoV serological status, year, demographic and habitat variables {#sec0045}
------------------------------------------------------------------------------------------

FCoV seroprevalence varied significantly by study year, origin and habitat variables (*p*  \< 0.05) ([Table 1a](#tbl0005){ref-type="table"}, [Table 1b](#tbl0010){ref-type="table"}). Furthermore, FCoV seroprevalence was 5% (1/19) and 41% (62/150) among FIV seropositive and seronegative cats, respectively (*p*  \< 0.05). Logistic regression analysis confirmed the independent relationship of FCoV serological status with examination year, age, FIV status, habitat and contact with other cats ([Table 2](#tbl0015){ref-type="table"} ).Table 2Estimates from the logistic-regression model of FCoV serological status conversion. A study of cats from Istanbul in 2009--14.VariableLevelOR95% CI*p* valueLowerHighExamination year20091------20100.540.083.540.522820110.140.011.350.089620120.570.113.010.508820130.720.153.550.691620147.571.2545.830.0275  Age (years)0.1--0.41------0.6--0.81.550.2210.860.658711.410.306.680.664123.980.8319.120.084437.571.3442.860.02224--151.320.286.230.7258  Home; outdoor accessHouse; no; no1------  Cohabitating with catsHouse; no; yes6.091.4825.030.0122House; yes; yes12.873.1552.570.0004Street; yes; yes3.120.7712.630.1111  FIV statusSeronegative1------Seropositive0.050.010.500.0106

3.3. Clinical symptoms, prognosis and relationship with FCoV serological status {#sec0050}
-------------------------------------------------------------------------------

Clinical examination revealed depression or dullness, fever and low body weight in 81% (137/169), 76% (128/169) and 70% (119/169) of study cats, respectively, and 57% (96/169) of cats had all three signs. The percentage of cats with ascites, abdominal distension and pleural effusion was 10% (17/169), 14% (24/169) and 5% (8/169), respectively. All three symptoms were present in only one cat, no cats had pleural effusion and ascites or abdominal enlargement alone; in contrast, ascites and abdominal enlargement without pleural effusion were observed in 9% (15/169) of cats and 19% (32/169) of cats presented one of these three conditions. The cat with all three symptoms was FCoV seronegative instead; FCoV seroprevalence was 93% (14/15) in cats with ascites and abdominal enlargement and 75% (24/32) in cats with at least one of the three symptoms, and 94% (30/32) of these were dull or depressed, had fever and/or low body weight.

The percentage of some clinical signs differed according to the cat\'s FCoV serological status ([Table 3a](#tbl0020){ref-type="table"} ). Other symptoms found included dyspnea (20/169), stomatitis (13/169), ocular signs (12/169), urinary tract signs (12/169) and epilepsy (2/169) (not shown in table format). The prevalence of these symptoms was not significantly different between FCoV seropositive and seronegative cats.Table 3aPercentage of cats with clinical signs according to their FCoV serological status. A study of cats from Istanbul in 2009--14.VariableFCoV*p* valueSeropositivesSeronegatives*N*No. affected% (95 CI)*N*No. affected% (95 CI)Fever634165 (53--77)1068782 (75--89)0.0211Depression or dullness634978 (68--88)1068883 (76--90)0.5235Weight loss633759 (47--71)1068277 (69--85)0.0144Vomiting63711 (3--19)1063533 (24--42)0.0027Abdominal distention631727 (16--38)10677 (2--11)0.0006Ascites631524 (13--34)10622 (0--4)\<0.0001Diarrhea63914 (6--23)10644 (0--7)\<0.0001Pleural effusion63610 (2--17)10622 (0--4)0.0532

Thirty-three percent of FCoV seropositive cats (21/63) and 12% (13/106) of seronegative cats died from the condition for which they were admitted in spite of receiving treatment (*p*  \< 0.05).

3.4. Hematological and biochemical parameters and relationship with FCoV serological status {#sec0055}
-------------------------------------------------------------------------------------------

Results of the hematology and clinical chemistry are shown in [Table 3b](#tbl0025){ref-type="table"} . Abnormalities were particularly frequent in cats with ascites and pleural effusion and 72% (23/32) and 76% (24/29) of cats with these signs had high WBC and low A:G ratio, respectively (not tabulated).Table 3bPercentage of cats with altered hematological and biochemical parameters according to their FCoV serological status. A study of cats from Istanbul in 2009--14.VariableFCoV*p* valueSeropositivesSeronegatives*N*No. affected% (95 CI)*N*No. affected% (95 CI)Hematology High WBC634165 (53--77)1064139 (29--48)0.0016 Low WBC6335 (0--10)1061817 (10--24)0.0369 High lymphocytic count631829 (17--40)1062221 (13--28)0.3326 Low lymphocytic count6346 (0--12)10698 (3--14)0.7690 High red blood cell count632133 (22--45)1062524 (16--32)0.2309 Low red blood cell count632032 (20--43)1062120 (12--27)0.1177 High hemoglobin635384 (75--93)1069691 (85--96)0.3140 Low hemoglobin6300 (0--0)10600 (0--0)1.0000 High hematocrit63914 (6--23)10666 (1--10)0.1038 Low hematocrit632946 (34--58)1063634 (25--43)0.1627Proteins High albumin6300 (0--0)6312 (0--5)1.0000 Low albumin632844 (32--57)6358 (1--15)\<0.0001 High globulin634765 (53--77)63711 (3--19)\<0.0001 Low globulin6300 (0--0)6300 (0--0)1.0000 High alb./glob. ratio6323 (0--8)6323 (0--8)1.0000 Low alb./glob. ratio634368 (58--80)63914 (6--23)\<0.0001 High total protein632743 (31--55)63914 (6--23)0.0008 Low total protein6300 (0--0)6300 (0--0)1.0000Kidney High BUN6300 (0--0)6346 (0--12)0.1190 Low BUN63610 (2--17)6300 (0--0)0.0276 High urea631524 (13--34)765066 (55--76)0.0001 Low urea6300 (0--0)7600 (0--0)0.2702 High creatinine6346 (0--12)7479 (3--16)0.7246 Low creatinine6300 (0--0)7400 (0--0)0.3473Liver High ALT631219 (9--29)1063533 (24--42)0.0747 Low ALT6300 (0--0)10622 (0--4)0.5296 High ALP6358 (1--15)6823 (0--7)0.2603 Low ALP6346 (0--12)6869 (2--16)0.7460 High bilirubin6300 (0--0)6523 (1--7)0.4962 Low bilirubin6300 (0--0)6500 (0--0)0.8597

4. Discussion {#sec0060}
=============

This study shows that FCoV infections are widespread in cats from Istanbul and this is in agreement with other studies elsewhere ([@bib0175], [@bib0120], [@bib0130], [@bib0155], [@bib0180], [@bib0115]). Moreover, FCoV seroprevalence increased in 2014 compared to previous years and this may suggest that FCoV infections are an increasing health problem in cats in Istanbul. High FCoV seroprevalence (up to 84%) has been reported in many countries ([@bib0175], [@bib0090], [@bib0145], [@bib0140], [@bib0150], [@bib0180]). In contrast, FCoV seroprevalence was comparatively low in chronically ill (19.3%) and even lower in healthy cats (10.1%) in Korea ([@bib0040]). Prevalence may vary depending on the inclusion criteria used (normal versus ill cats) and estimates may be affected by selection bias, analytical errors and imperfect diagnostic tests.

Several risk factors have been reported to be associated with FCoV infection and with FIP development, including age, breed, gender, multi-cat environment and stress ([@bib0015], [@bib0130], [@bib0005], [@bib0155], [@bib0215]). In the present study, FCoV serological status was significantly associated with year, age, FIP serological status and habitat variables. The risk of infection would be expected to rise during the first months or years of life due to increasing cat-to-cat contact. However, it is possible that infection prevalence among 0.1--0.4 year-olds may have been underestimated as several weeks would be needed for anti-FCoV antibodies to develop following infection. Other studies have reported greater FCoV prevalence in cats 3--11 months of age ([@bib0015], [@bib0125], [@bib0180]). Instead, a study in Australia and Malaysia found no association between age and FCoV infection in cats ([@bib0015], [@bib0155]).

Household cats living alone had the lowest risk of being FCoV seropositive, as reported in other studies ([@bib0005], [@bib0045]). In contrast, this study found that household cats that cohabitated with other cats had a high risk of being FCoV seropositive, as has been previously shown ([@bib0055], [@bib0085], [@bib0120], [@bib0130], [@bib0155], [@bib0150]). Moreover, in the present study, FCoV seroprevalence was lower in stray cats (30%) compared to cats living at home (57%). It is possible that stray cats have poorer health and increased risk of dying from FCoV infections compared to household cats. Alternatively, stray cats could be exposed to less FCoV compared to household cats, who commonly share the same litter box and eat from the same food bowl as other cats in the household. Furthermore, immunological differences could exist between stray and household cats, with the latter being naturally selected for a protective Th-1 mediated rather than a Th-2 antibody mediated response. This, however, has not been investigated and remains speculative.

Interestingly, FIV seroprevalence was negatively associated with FCoV infection in this study. The reason for this is unclear. It could be because household cats are vaccinated for FIV in Istanbul. It is also possible that coinfected cats are at greater risk of dying as a result of FIV immunosuppression compared to cats that are only FCoV seropositive.

In the present study, no difference in FCoV seroprevalence was found between females and males. Similar results have been found by others ([@bib0035], [@bib0015], [@bib0090], [@bib0155], [@bib0180]). Instead, in Australia and the USA, male cats were found to be more frequently infected with FCoV ([@bib0130], [@bib0215]). There is no known biological reason supporting gender-associated susceptibility and resistance to FCoV, and differences between studies could be related to males and females having different lifestyles and FCoV exposure.

Breed was not associated with FCoV seropositivity in the present study. In contrast, higher FCoV seroprevalence has been reported in purebred cats compared to non-pedigree cats in several studies ([@bib0015], [@bib0130], [@bib0090], [@bib0180]). In Japan, seroprevalence was higher among pedigree cats including American curl, Maine coon, Norwegian forest cat, Ragdoll and Scottish fold compared to American shorthair, Himalayan, Oriental, Persian, and Siamese ([@bib0180]). In Australia, Siamese, Persian, Domestic Shorthairs and Bengal cats had significantly lower prevalence than British Shorthairs, Cornish Rex and Burmese cats ([@bib0015]). Australian studies reported FCoV to be prevalent among British Shorthair, Devon Rex and Abyssinian breeds ([@bib0215]). In Malaysia, FCoV seroprevalence was higher in Persian (96%) than in mix-breed cats (70%) ([@bib0155]). In the present study there were too few cats of specific breeds to allow robust statistical comparisons. Moreover, pure and mixed breed cats did not differ significantly in terms of street access and contact with other cats.

Critical evaluation is necessary for a cat to be diagnosed with FIP. Diagnosis is based on evaluation of history, symptoms, hematological and biochemical parameters, diagnostic tests, radiology and tissue biopsy results ([@bib0165], [@bib0170], [@bib0080], [@bib0005], [@bib0125], [@bib0160], [@bib0190]). It has been reported that up to 12% of FCoV infected cats develop FIP ([@bib0075], [@bib0005], [@bib0125]). Although in the present study no definitive diagnosis of FIP was attempted, 19% of cats had typical signs of wet FIP including abdominal distension, ascites and pleural effusion, and increased γ-globulin and decreased albumin-to-globulin (A:G) ratio. Differences in the percentage of FCoV cats developing FIP between studies could be associated with the cat populations examined; cats investigated in this study were clinically ill and suspected of having a viral infection.

5. Conclusions {#sec0065}
==============

This study indicates that FCoV infection in cats from Istanbul is high and possibly increasing. Preventive actions are necessary in multi-cat environments (shelters, catteries and pet shops) and single household cats with outdoor access. Cats presenting with general malaise, including fever not responding to antibiotics, depression, ascites, abdominal distension, diarrhea, pleural effusion, postsurgical complications and a low A:G ratio should be suspected of suffering from FIP.
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